Education
About Us
Working with TipRanks
Follow Us
Tectonic Therapeutic (TECX)
NASDAQ:TECX
Total Valuation
Tectonic Therapeutic has a market cap or net worth of $383.12M. The enterprise value is ―.
Market Cap$383.12M
Enterprise Value―
Share Statistics
Tectonic Therapeutic has 18,716,280 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,716,280
Owned by Insiders38.51%
Owned by Institutions28.17%
Financial Efficiency
Tectonic Therapeutic’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -40.27%.
Return on Equity (ROE)-0.41
Return on Assets (ROA)-0.38
Return on Invested Capital (ROIC)-40.27%
Return on Capital Employed (ROCE)-0.41
Revenue Per Employee0.00
Profits Per Employee-1.14M
Employee Count51
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tectonic Therapeutic is ―. Tectonic Therapeutic’s PEG ratio is 0.16.
PE Ratio―
PS Ratio0.00
PB Ratio2.78
Price to Fair Value2.78
Price to FCF-6.62
Price to Operating Cash Flow-5.51
PEG Ratio0.16
Income Statement
In the last 12 months, Tectonic Therapeutic had revenue of 0.00 and earned -57.98M in profits. Earnings per share was -3.93.
Revenue0.00
Gross Profit0.00
Operating Income-58.02M
Pretax Income-57.98M
Net Income-57.98M
EBITDA-56.23M
Earnings Per Share (EPS)-3.93
Cash Flow
In the last 12 months, operating cash flow was -62.44M and capital expenditures -238.00K, giving a free cash flow of -62.68M billion.
Operating Cash Flow-62.44M
Free Cash Flow-62.68M
Free Cash Flow per Share-3.35
Dividends & Yields
Tectonic Therapeutic pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.44
52-Week Price Change-60.41%
50-Day Moving Average17.53
200-Day Moving Average20.50
Relative Strength Index (RSI)58.79
Average Volume (3m)550.68K
Important Dates
Tectonic Therapeutic upcoming earnings date is Mar 19, 2026, TBA (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateMar 19, 2026
Ex-Dividend Date―
Financial Position
Tectonic Therapeutic as a current ratio of 12.65, with Debt / Equity ratio of 0.46%
Current Ratio12.65
Quick Ratio12.65
Debt to Market Cap0.00
Net Debt to EBITDA2.45
Interest Coverage Ratio-542.20
Taxes
In the past 12 months, Tectonic Therapeutic has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Tectonic Therapeutic EV to EBITDA ratio is -4.52, with an EV/FCF ratio of -4.29.
EV to Sales0.00
EV to EBITDA-4.52
EV to Free Cash Flow-4.29
EV to Operating Cash Flow-4.30
Balance Sheet
Tectonic Therapeutic has $268.44M in cash and marketable securities with $1.24M in debt, giving a net cash position of $267.20M billion.
Cash & Marketable Securities$268.44M
Total Debt$1.24M
Net Cash$267.20M
Net Cash Per Share$14.28
Tangible Book Value Per Share$16.58
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tectonic Therapeutic is $86.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$86.25
Price Target Upside321.35% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast60.40%